multiple dose bioequivalence study [Design Issues]

posted by Loky do – Egypt, 2020-08-09 11:50 (779 d 12:19 ago) – Posting: # 21842
Views: 2,216


If we have solifenacin 6 mg (immediate-release) / tamsulosin 0.4 mg modified-release product combination, is multiple-dose bioequivalence study required to be submitted to the European authorities in addition to fast & fed studies, as there is no specific guidance for this product & in GCC region fast & fed studies only accepted.

Thanks in advance

Complete thread:

UA Flag
 Admin contact
22,391 posts in 4,685 threads, 1,595 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Wednesday 00:10 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz